BETA Technologies, Inc.'s robust order backlog, strategic partnerships & strong patent portfolio provide a competitive moat.
Investor's Business Daily on MSN
Beta Bionics Joins Rank Of Stocks With RS Ratings Over 90
Beta Bionics earns the No. 39 rank among its peers in the Medical-Products industry group. TransMedics Group TMDX, Insulet ...
In isolation, the price/earnings (PE) multiple only tells us so much. One obvious limit is that while share prices are always positive, earnings aren’t. And a negative PE is meaningless.
Zacks Investment Research on MSN
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say
For the quarter ended September 2025, Beta Bionics, Inc. (BBNX) reported revenue of $27.25 million, representing no change compared to the same period last year. EPS came in at -$0.33, compared to $0 ...
The Independent on MSN
Less trick, more treat: Why pumpkins are the ultimate gut-health superfood
Carved, scooped and left to rot, millions of pumpkins are binned every Halloween – but beneath their spooky grin lies one of ...
Get key insights from Beta Bionics’ Q3 2025 earnings: record growth, raised revenue guidance, strong iLet adoption, and innovation pipeline.
Meta is scheduled to report third-quarter results after the closing bell on Wednesday, with traders betting on a big move in ...
Google parent Alphabet is scheduled to report third-quarter results after the closing bell on Wednesday, with traders betting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results